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This document provides guidelines for the terminology, method-
ology, andfor the interpretation ofdata obtainedfrom the use ofskin
(transcutaneous) Po2 and Pco2 electrodes. The transcutaneous
technique has found special application in newborn infants. The
causes of analytical bias with respect to arterial blood gas values,
and imprecision obtained with transcutaneous Pcog_ electrodes, are
reviewed. Electrode temperatures above 44C should not be used
routinely, and, at a measuring temperature of44C, the measuring
site should be changed at least every 4 h to avoid skin burns.
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2. Definitions, terminology and abbreviations
The Po (or Pco) of the heated skin surface is usually
used as an indirect (transcutaneous) measure of thePo
(or Pco2) of arterial blood. In this case, the system of
measurement is arterial blood, although the result is
modified by the special transcutaneous technique, and
the correct symbol in line with IFCC/IUPAC [3] is
PO:(aB, tc) (or PCO(aB, tc)), which may be shortened to
Po2(tc (or Pco2(tc) ).
An alternative viewpoint is that the measu,rement system
is the heated skin surface and the quantity is therefore
distinct from the Po (or Pc02) of arterial blood. In this
case, it is more appropriate to use the symbol Po(s) (or
Pco(s)), where S is the heated skin surface. Other
commonly used symbols for transcutaneousP02 (orpco)
are tcpO (or tcpCO2), ptcO2 (or ptcCO2), PtcO2 (or
PtcCO) and PsO2 (or PsCO), although these are not in
line with IFCC/IUPAC definitions [3].
1. Introduction
Electrodes for transcutaneous measurements of oxygen
and carbon dioxide are widely used to monitor con-
tinuously and non-invasively the oxygen and carbon
dioxide status of patients with cardio-respiratory dis-
orders. The transcutaneous technique has found special
application in newborn infants, whose skin is thinner and
has a greater density of capillaries, and in whom
transcutaneousPo correlates closer to arterial bloodPo
than in adults. The purpose ofthis document is to provide
guidelines for the terminology, methodology, and for the
interpretation of data obtained from the use of skin
electrodes. Arterial blood gas values are the reference
points, and should be measured in connection with
transcutaneous measurements. Recommendations cover-
ing the technical aspects of transcutaneous electrodes
have been prepared by The American Society for Testing
and Materials and The International Electrotechnical
Commission [2].
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3. Physiological basis for transcutaneous gas
measurements
For a comprehensive review the reader is referred to
Huch et al. [4], as well as the proceedings of the
international symposia on continuous blood gas monitor-
ing [5, 6].The measured transcutaneous values are the
result of several variables, which in turn are modified by
heating the skin surface [7].
3.1. Variables determining Po2(tc) and Pco2(tc)
(a) Arterial blood Po2 and Pco (PO2(aB) and PCO(aB)),
and, to a lesser extent, the position and shape of the
oxygen and carbon dioxide binding curves.
(b) Capillary blood flow in the skin under the electrode.
(c) Oxygen consumption and carbon dioxide production
by the skin.
(d) Oxygen consumption by the electrode.
(e) Temperature gradients in the skin.
(J) Structure and diffusive properties of the skin.
3.2. Effects ofheating the skin surface
(a) Increase in capillary blood flow in the skin under the
electrode, with diminished arterio-venous differences
in Po2 and Pco2.
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(b) Lowered blood solubility of O2 and CO2, as well as
lowered haemoglobin-oxygen affinity and increased
dissociation of carbonic acid. All these factors cause
an increase in Po2 and Pco2 in the heated blood.
(c) Increased diffusion of gases through the skin due to
solubilization of the lipid layer of the epidermis.
(d) Increased O2 consumption and CO2 production by
the skin.
From this it follows that the relation between PO2(aB and
Pco2(tc) is complex, as is that between PCO2(aB) and
Pco2(tc) (see section 8.2).
4. Instrumentation and equipment
4.1. The electrode system
Transcutaneous Po2 electrodes are heated Clark-type
electrodes, and transcutaneous Pco2 electrodes are
heated Stow-Severinghaus electrodes. The two sensors
may be combined in a single housing with a common
electrolyte solution, membrane, and Ag/C1 reference
electrode. The system contains a thermostatically
controlled heating element with preset temperatures
ranging from 37"0 to 45"0C. Although not presently
available, optical sensors for the measurement ofpo2(tc)
and Pco2(tc) are under development [8, 9].
5.1. Po2(tc) electrode
Zero adjustment is usually performed automatically,
assuming zero current at zero Po2, but may be checked
with a ’zero’ solution containing an oxygen consuming
agent, such as sodium sulphite or with N2 gas.
Calibration is generally made with atmospheric air, or
with a certified gas mixture containing known fractions of
oxygen and carbon dioxide, balanced with nitrogen.
The Po2 of atmospheric air is:
PO2(atm) 0"2093 X (p(atm)-PH20(atm))
where 0"2093 is the volume fraction ofO2 in atmospheric
air, p(atm) is the ambient pressure, PH20(atm) is the
partial pressure ofH20 in the air, and may be calculated
from the relative humidity (rH20) and the saturated water
vapour pressure at the ambient temperature (PH20).
For example." ifp(atm) 100 kPa, PH20 2"6 kPa, rH20
0"4, thenpo2(atm) 0"2093 X (100 (2"6 X 0"4)) kPa
20" 7 kPa.
The electrode sensitivity (d Current/dpo2) should be
within the manufacturer’s specified limits, which depend
on the cathode size and the membrane permeability and
thickness. Furthermore, a stable calibration value should
be attained within 3 min. Failure to satisfy these
requirements should be indicated by an error message.
4.2. The monitor
The monitor should include:
(a) Circuitry for Po2 and Pco2 measurement.
(b) Heating and temperature control from 37"0 to
45.0C.
(c) Preferably a digital display, and outputs for recorder
and for printer ofpo2, Pco2 and heat consumption by
the heating element.
(d) Calibration adjustment controls.
(e) Means of testing the electrical resistance of the
membrane.
(d) Alarm (visual and auditory) which activates if (1)
Po2(tc) orpco2(tc) are outside pre-set limits selected by
the clinician, or (2) electrode temperature deviates
by more than 0"3C from the selected temperature.
5. Calibration
Calibration should be performed at the electrode measur-
ing temperature immediately prior to use and before each
re-application of the electrode to the patient (i.e.
normally every 4 h or less). Any fluid droplets on the
outer side of the electrode membrane should be carefully
removed before calibration. Calibration gas mixtures
should have a relative inaccuracy of less than +0"5% of
the stated value. The composition of the gas mixtures
does not change with storage.
5.2. Pco2(tc) electrode
Two-point calibration is performed at least once a day
with two dry gas mixtures with known CO2 fractions, for
example 0"05 and 0"10 (Pco2 about 5 and 10 kPa
respectively), with a one-point calibration (for example,
with FcO2(G) 0"05) more frequently.
The Pco2 of a dry gas is:
PCO2(G) FCO2(G) p(atm).
For example, ifp(atm) 100 kPa and Fo2(6) 0"05,
PCO2(G) 0"05 X 100 kPa 5"0 kPa.
The electrode sensitivity (dE/dlgpco2) should be within
5% of the theoretical.
6. Measurement procedure
A typical protocol is described, details ofwhich may vary
according to the electrode system and monitor used.
Detailed instructions should be found in the manuals
produced by the manufacturers.
6.1. Selection of measurement site
Optimal measuring conditions are obtained in skin areas
with high density of capillaries, ample capillary blood
flow, thin epidermis, and small or no deposits of fat. The
optimal places are the lateral sides of the abdomen and
chest. The arms and legs are best avoided, as vasocon-
striction, reducing skin blood flow, occurs earlier here if
the patient becomes cold or hyp0tensive. In those
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newborn infants where there is a possibility ofright-to-left
shunting through the ductus arteriosus, the electrodes must
be placed on the right upper chest to detect/avoid high
Po2 levels in the blood supplying the retina.
recommended calibration period of 4 h. The gas should
have the same temperature and flow rate as that used for
calibration.
6.2. Preparation of skin
Hair should be removed to ensure better adhesion.
Cleaning the skin with alcohol is recommended.
6.3. Fixation of the electrode
Fixation to the skin is facilitated by a self-adhesive ring.
6.9. Use of recorder
A recorder is recommended because it has the advantage
of providing retrospective analysis of changes in po2(tc
andPeo2(tc). A recorder, however, increases the size ofthe
monitoring system, and reduces its portability. Trends
may also be observed by a visual display unit.
6. 4. Contact liquid
Contact between the electrode and the skin is best
ensured by a thin layer of fluid (for example, water or
glycerol). It is important to avoid the presence of air
between the electrode and the skin, and not to moisten the
adhesive tape.
6.5. Selection of electrode temperature
Po2(tc) is usually measured at 44C, and Pco2(tc) at 42C
(except in the combinedpo2/Pco2 sensor wherePco2(tc) is
also measured at 44C). The higher temperature is
necessary for Po(tc) because of the poorer diffusion ofO2
through the skin, compared to CO, and because of the
greater arteriovenous differences for Po2 compared to
Pco. Serious skin burns may occur with electrode
temperatures over 44C, even with measuring times
under 4 h (see section 7.1).
6.6. Comparison with arterial blood values
In order to ensure the correct interpretation oftranscuta-
neous values, at the start of each patient monitoring
period, the relationship between Po(tc) and Po2(aB), and
between Pco(tc) and PCO2(aB), should be established.
Furthermore, it should be remembered that any change
in Po(tc) may be due to either a change in PO2(aB), or due
to a change in skin blood flow (see section 8.2.1). Po(tc)
and Pco(tc) only reflect PO2(aB) and PCO(aB), respect-
ively, at relatively high local blood flow.
Capillary blood cannot replace arterial blood as the
reference system because the presence of even very small
amounts ofvenous blood, which commonly contaminate
the specimen, may result in a marked decrease in
capillary blood Po2 compared to arterial blood Po.
6.7. Measurement time
(See section 7.1.)
6.8. Electrode drift check
After removal from the skin, the electrode reading should
be checked in a calibration gas, in order to document any
electrode drift which may have occurred during measure-
ment on the skin (see section 5). This should be less than
+5% for both Po2(tc) and Pco2(tc) over the maximum
7. Patient safety
7.1. Avoidance ofskin burns
Prolonged application of a heated transcutaneous elec-
trode may cause skin burns. For this reason an electrode
temperature above 44C is not recommended for routine
clinical monitoring.
At an electrode temperature of 44C, the electrode
measuring site must be changed at least every 4 h, in
order to avoid blister formation. Even after shorter
measuring times, the skin will show erythema when ,the
electrode is removed, though this erythema disappears
after one or two days. The risk ofskin burning is increased
in patients with peripheral circulatory failure, and in very
small, premature infants and therefore the measuring site
should be changed more frequently, for example every 2-
3 h. An alarm should be included to ensure that the device
automatically turns off within a few seconds, should the
electrode core temperature rise above 46 C.
Two thermistors are recommended to ensure back up in
the event of failure.
See also section 9.1 on electrode temperature control.
7.2. Electrical safety
All equipment used should be certified by its manufac-
turer to comply with a national or international electrical
safety standard. The equipment must not interfere
electrically with other equipment (for example an electro-
cardiogram or a heart pacemaker) attached to the
patient.
8. Performance characteristics
8.1. Imprecision
Imprecision may be due to the electrode drift, variations
in pressure on the electrode, and the variable properties of
the skin. Coefficients of variation (CV) determined from
duplicate measurements in the same individual may be
expected to be about 10% for Po2(tc and 5% for Pco2(tc)
[10, 11]. These figures include both biological and
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analytical variation. The same electrode should have a
CV of only 1-2%, when duplicate measurements are
made in dry gases [10].
8.2. Accuracy
8.2.1. Bias in Po2(tc): Po2(tc values at 44C are approxima-
tely equal to po2(aB values at 37C in newborn infants
[4, 12, 13]. However, large biases in Po2(tc) are common
[10], especially in adults [7, 14] due to the following
causes:
(a) Variation in the Po2 temperature coefficient with
increasingPo2 level, gives a negative bias in Po2(tc) at
high Po2 levels, i.e. Po2(tc) reads too low. Other
factors, for example abnormal total haemoglobin
concentration and an altered haemoglobin oxygen
affinity, also give a bias, but these effects are smaller
[15].
(b) Variation in skin capillary blood flow: decrease in
skin capillary blood flow causes a decrease in Po2(tc)"
Changes in blood flow may be due to sepsis, changes
in blood Pco2, administ.ration of drugs, for example
tolazoline and catecholamines, and furthermore may
be general or localized to the area of skin under the
electrode.
(c) Variations in skin anatomy: increasing skin thickness
and decreasing skin vascularization, which, for
example occur with increasing age, result in low
Po2(tc values. Differences in skin anatomy between
various parts of the body also cause bias.
(d) Interference from anaesthetic gases: halothane and
nitrous oxide may give falsely elevated Po2(tc) values
[16-19].
Due to the large variations in the degree of bias, Po2(tc)
cannot be used to replacePO2(aB). The major use ofpo(tc)
is as a trend parameter for continuous non-invasive
monitoring, using PO(aB) as the reference point.
However, in adults, studies have shown that Po2(tc) is
often not a trend indicator of PO2(aB), but may be a
valuable indicator of tissue Po in preterminal and
terminal patients during periods of hypoxic shock and
cardiac arrest [20-22].
8.2.2. Bias in Pco2(tc): Pco2(tc) values at 42-45C are
higher than Pco2(aB) at 37 C. However, the relative bias
is much more constant than that forpco(tc) [10, 11], such
that when corrected to body temperature, Pco2(tc)
provides a better indicator ofPco(aB) than can be said for
Po2(tc) and PO2(aB)- Several methods of ’correcting’
PCO2(tc) to estimate PCO2(aB) have been used, but none
have been sufficiently well documented to be considered
as standard. A single factor is known to be insufficient in
that, when normal values are correctly obtained, the
resulting slope of the electrode is low for changes from
normal, underestimating the degree of abnormality in
either direction. An empiric ’skin metabolism offset’ of
about 0"8 kPa used in connection with a temperature
coefficient, dlnpco/dO 0.04 X C-1 (corresponding to
about 4% per C), has been shown to provide reasonable
correction and tracking ofvariation ofPco values, i.e. the
Pco2(te) value measured at an electrode temperature 0(E)
is divided by exp (0.04 ((0(E)/C) 37)) and then
reduced by 0"8 kPa. The temperature coefficient of 0"04
used here is slightly lower than the anaerobic tempera-
ture coefficient for Pco2 in blood (dlnpco/dO 0"048
C-1 [23]) because the skin capillary temperature is
slightly lower than the electrode temperature [24, 25].
9. Quality assurance
9.1. Electrode temperature control
Temperature control should be accurate to within 0’3 C.
This should be checked periodically by placing the
electrode in a temperature-controlled environment. With
the heater power off, the electrode monitor’s temperature
measurement should be within +0"3C of the environ-
mental temperature [1]. With heater power on, and
monitor temperature set to the environmental tempera-
ture, the monitor heat output should read zero.
9.2. Electrode drift rate
When placed in a calibration gas, Po and Pco should
not drift more than +1% per hour. For drift during
patient monitoring, see section 6.8.
9.3. Changes in heat consumption during patient
monitoring
A decrease in Po2(tc value, together with decreased heat
dissipated by the heating element, indicates reduced
blood flow in the skin capillaries and in the deeper and
larger vessels under the electrode, and not necessarily
reduction inPO2(aB). However, changes in heat consump-
tion also occur with changes in the environmental and the
patient’s temperature.
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Addendum
Since the approval of this document by IFCC, there has
been an increasing interest in the possibility of using
transcutaneous Po2 and Pco2 on human foetal scalp
during labour as an additional parameter to detect foetal
asphyxia. Although several authors advocate this tech-
nique [1, 2], the technical problems, and the importance
of a simultaneous scalp blood flow measurement [3],
necessarily limit this application to research purposes at
present.
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